Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
200 participants
INTERVENTIONAL
2024-10-31
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Does TMS improve the visual outcome in patients after cataract surgery? Researchers will compare TMS to the sham-controlled treatment (exposure to recorded sounds of pulses without real magnetic stimulation) to see if TMS works to improve the visual outcomes of patients after cataract surgery.
Participants will
* Undergo TMS treatment or a sham-controlled treatment for consecutive 5 days.
* Visit the clinic once every 2 weeks for checkups and tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation on Visual Outcome of TMS
NCT06612190
Visual Functional Connectivity and Visual Improvement After TMS/Binocular Treatment
NCT03151200
Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment
NCT06192433
The Consciousness Variation of Deep Brain and Transcranial Magnetic Stimulation for Disorders of Consciousness Patients
NCT02667899
Effects of Transcranial Magnetic Stimulation (TMS) on Somatosensory Perception
NCT02119637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TMS
TMS treatment indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
TMS
TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
Control
The sham group will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
control group
The control treatment is a sham-controlled procedure, in which participants will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TMS
TMS treatment in this study indicates a non-invasive procedure called transcranial magnetic simulation (TMS) on visual cortex. The treatment intensity is set as 80% of the threshold of each participant. The treatment will be conducted every day for consecutive 5 days.
control group
The control treatment is a sham-controlled procedure, in which participants will be exposed to the recorded sounds of TMS pulses but without real magnetic stimulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best-corrected visual acuity less than 0.1logMAR
Exclusion Criteria
* Diagnosed with significant opacity of refractive media that affects observation of visual function;
* History of epileptic seizures;
* Long term use of psychotropic drugs;
* Metal implants in the body.
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai High Myopia Study Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangjia Zhu
Role: STUDY_CHAIR
Eye and ENT Hospital of Fudan University
Jiaqi Meng
Role: PRINCIPAL_INVESTIGATOR
Eye and ENT Hospital of Fudan University
Yinglei Zhang
Role: PRINCIPAL_INVESTIGATOR
Eye and ENT Hospital of Fudan University
Yating Tang
Role: PRINCIPAL_INVESTIGATOR
Eye and ENT Hospital of Fudan University
Xin Liu
Role: PRINCIPAL_INVESTIGATOR
Eye and ENT Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye and Ear, Nose Throat Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMSG2024015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.